Search - tctmd.com

Displaying 261 - 280 of 444

Sort: Relevancy | Date

News Daily News

Registry Study Explores Potential for TAVR in Low-, Intermediate-Risk Patients

May 13, 2013

News Daily News

Post-TAVR Coronary Obstruction Risk Low, Linked to Unfavorable Anatomic Features

L.A. McKeown

May 13, 2013

News Daily News

El Bajo Riesgo de Obstrucción Coronaria Post-TAVR se asocia a Características Anatómicas Desfavorables

L.A. McKeown

May 13, 2013

News Daily News

PARTNER Substudy Looks at Echocardiographic Differences Between TAVR, Surgery

Caitlin E. Cox

April 26, 2013

News Daily News

El Subestudio PARTNER Analiza las Direrencias Ecocardiográficas existentes entre la TAVR y la Cirugía

Caitlin E. Cox

April 26, 2013

Presentation TCTAP 2013

Update of New TAVI Indications

Presenter: Thierry Lef?vre

April 25, 2013

Presentation TCTAP 2013

TAVI Technology and Procedural Changes

Presenter: Eberhard Grube

April 25, 2013

Presentation TCTAP 2013

How to Choose TAVI or SAVR

Presenter: I. Sheiban

April 25, 2013

Presentation TCTAP 2013

Controversies: TAVI is Preferred in All High-Risk Patients

Presenter: Alain Cribier

April 24, 2013

Presentation

Clinical Outcomes of Patients with Estimated Low or Intermediate Surgical Risk Undergoing TAVI

Presenter: Peter Wenaweser

April 01, 2013

News Conference News ACC 2013

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

Yael L. Maxwell

March 11, 2013

News Daily News

Myocardial Injury Common with TAVR, Prognostic Only If Accompanied by AKI

Yael L. Maxwell

March 09, 2013

News Daily News

La Lesión Miocárdica es Frecuente con la TAVR, el Pronóstico solo puede dares si está Acompañada de LRA

Yael L. Maxwell

March 09, 2013

News Industry News

Medtronic Announces CE Mark for Engager™ Transcatheter Valve

February 27, 2013

News Industry News

Loma Vista Medical reports that it is ramping up sales in U.S. and Europe of its FDA-cleared and CE-marked TRUE Dilatation™ Balloon Valvuloplasty Catheter

February 12, 2013

Presentation TCT 2013

TransAortic Valve Implantation (TAVI) Normalises Subendocardial Function in Patients with Severe Aortic Stenosis

Presenter: Alison Duncan, Thomas Snow, Carlo Di Mario, Simon Davies, Neil Moat

January 31, 2013

Presentation TCT 2013

Standardized Segmentation of Aortic Annulus Across Multi-modalities Imaging Technics. Location of annulus calcification Predicts Periprosthetical Leaks post TAVI.

Presenter: VLAD CIOBOTARU, eric maupas

January 31, 2013

Presentation TCT 2013

Report from the Swedish TAVI register: Comparison of two valve types.

Presenter: Jan Harnek, Wolfgang Freter, Peter Holm, Dan Ioanes, Stefan James, Johan Nilsson, Andreas Ruck, Leszek Zagozdzon

January 31, 2013

Presentation TCT 2013

Qualitative Assessment on TAVI utilization: a European Perspective

Presenter: Dario Remigi, Pascale Brasseur, Kilian Toal, Rachele Busca

January 31, 2013

Presentation TCT 2013

Outcome after a TAVI procedure with self expanding bioprothesis using Corevalve or Accutrack delivery device: France 2 Registry results.

Presenter: Gauthier Mouillet, Eric Van Belle, masanori yamamoto, Nicolas Lellouche, Delphine Hayat, Jean Luc Monin, Alain Prat, Marc Laskar, Martine Gilard, Emmanuel Teiger

January 31, 2013

Advertisement

Registry Study Explores Potential for TAVR in Low-, Intermediate-Risk Patients

Post-TAVR Coronary Obstruction Risk Low, Linked to Unfavorable Anatomic Features

El Bajo Riesgo de Obstrucción Coronaria Post-TAVR se asocia a Características Anatómicas Desfavorables

PARTNER Substudy Looks at Echocardiographic Differences Between TAVR, Surgery

El Subestudio PARTNER Analiza las Direrencias Ecocardiográficas existentes entre la TAVR y la Cirugía

Update of New TAVI Indications

TAVI Technology and Procedural Changes

How to Choose TAVI or SAVR

Controversies: TAVI is Preferred in All High-Risk Patients

Clinical Outcomes of Patients with Estimated Low or Intermediate Surgical Risk Undergoing TAVI

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

Myocardial Injury Common with TAVR, Prognostic Only If Accompanied by AKI

La Lesión Miocárdica es Frecuente con la TAVR, el Pronóstico solo puede dares si está Acompañada de LRA

Medtronic Announces CE Mark for Engager™ Transcatheter Valve

Loma Vista Medical reports that it is ramping up sales in U.S. and Europe of its FDA-cleared and CE-marked TRUE Dilatation™ Balloon Valvuloplasty Catheter

TransAortic Valve Implantation (TAVI) Normalises Subendocardial Function in Patients with Severe Aortic Stenosis

Standardized Segmentation of Aortic Annulus Across Multi-modalities Imaging Technics. Location of annulus calcification Predicts Periprosthetical Leaks post TAVI.

Report from the Swedish TAVI register: Comparison of two valve types.

Qualitative Assessment on TAVI utilization: a European Perspective

Outcome after a TAVI procedure with self expanding bioprothesis using Corevalve or Accutrack delivery device: France 2 Registry results.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content